Pre-Surgery workout may boost liver donor recovery
NCT ID NCT05431361
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a personalized exercise program (prehab) before living liver donation is practical and helpful. Thirty donors followed a remote exercise plan for at least 28 days before surgery. The goal was to see if a larger trial is possible, not to prove the program works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Prehabilitation (exercise program)
- What this could lead to
- If this approach works, it could improve recovery and quality of life for living liver donors after surgery.
- What could go wrong
- This was a small, early feasibility study with only 30 participants. It was not designed to prove that prehab actually improves recovery, so results may not be conclusive.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVING DONOR LIVER TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Health Network
Toronto, Ontario, M5G 2C4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single infusion of 'Trainer' cells free liver transplant patients from lifelong drugs?
- New study aims to sharpen predictions for liver transplant success
- Liver regrowth secrets: new study tracks donor recovery
- New study could spare liver donors from unnecessary needle biopsies
- Liver transplants without blood type matching: a new hope?
- Could a cell infusion free liver transplant patients from lifelong drugs?